Trials / Completed
CompletedNCT04594577
Clinical Validation of the Fluispotter System for Serial Sampling of Venous Dried Blood Spots
The Clinical Validation of Fluispotter®, a Novel Automated Body-worn System for Serial Sampling of Venous Dried Blood Spots
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Fluisense ApS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective, single-centre, non-comparative, non-randomized, open label, clinical investigation of the clinical performance and safety of Fluispotter. The main aim is to validate the clinical performance and safety of the body-worn Fluispotter system used for automated extraction, collection and storage of 20 dried venous dried blood spot samples of 10 µl over the course of 20 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fluispotter | Fluispotter automated blood sampling system applied for venous blood sampling of 20 10 μL samples in a 20 hours sampling session. |
Timeline
- Start date
- 2021-01-27
- Primary completion
- 2021-03-22
- Completion
- 2021-03-22
- First posted
- 2020-10-20
- Last updated
- 2021-05-27
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04594577. Inclusion in this directory is not an endorsement.